Protara Therapeutics (TARA) Return on Capital Employed Growth (3y) (2018 - 2026)
Protara Therapeutics (TARA) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.46 Bn | 470.67 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.19 Bn | 115.94 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.44 Bn | 60.69 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 57.08 Bn | 51.90 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.11 Bn | 38.11 Bn | - | -3,782.00 |
| 10 | Protara Therapeutics | 236.77 Mn | 236.77 Mn | - | 2,720.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,720.00 |
| Dec 31, 2025 | 1,471.00 |
| Sep 30, 2025 | -1,687.00 |
| Jun 30, 2025 | -1,116.00 |
| Mar 31, 2025 | -332.00 |
| Dec 31, 2024 | -1,121.00 |
| Sep 30, 2024 | -2,594.00 |
| Jun 30, 2024 | -3,264.00 |
| Mar 31, 2024 | -4,774.00 |
| Dec 31, 2023 | -3,884.00 |
| Sep 30, 2023 | -6,275.00 |
| Jun 30, 2023 | -3,710.00 |
| Mar 31, 2023 | -1,009.00 |
| Dec 31, 2022 | 32,207.00 |
| Sep 30, 2022 | 8,467.00 |
| Jun 30, 2022 | 7,266.00 |
| Mar 31, 2022 | 7,325.00 |
| Sep 30, 2021 | 8,726.00 |
| Jun 30, 2021 | 7,262.00 |
| Mar 31, 2021 | 7,716.00 |